Delivery Order SPE2DR25D1100-SPE2DR26FDP2A

The Defense Logistics Agency issued a $1,754.28 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Hemangeol 4.28 mg/ml oral solution 120 ml. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026. This vehicle supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm...

The Defense Logistics Agency issued a $2,192.85 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for Hemangeol 4.28 mg/ml oral solution 120 ml, with an ultimate completion date of April 9, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis and carries no set-aside. The parent vehicle is an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supports global...

The Defense Logistics Agency issued a $1,315.71 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for HEMANGEOL 4.28 mg/mL oral solution 120 mL, with an ultimate completion date of March 31, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999 through December 2026), which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken,...

The Defense Logistics Agency awarded a delivery order valued at $1,263.27 to AmerisourceBergen Drug Corp for Hemangeol 4.28 mg/mL oral solution (120 mL) on June 2, 2025, with an ultimate completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. Hemangeol is a cardiovascular medication used to treat infantile hemangiomas, and this procurement...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,775.04 to supply Hemangeol 4.28 mg/ml oral solution (120ml) with a completion date of January 6, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...

The Defense Logistics Agency awarded a $1,754.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Hemangeol 4.28 mg/ml oral solution (120 ml). The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 26, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...

The Defense Logistics Agency awarded a $10,106.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hemangeol 4.28 mg/mL oral solution (120 mL) on August 29, 2025, with completion targeted for September 22, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,656.80 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Cencora, Inc. doing business as Amerisourcebergen. The contract is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a completion date of March 26, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up...

This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has a ceiling value of $1,263.27 and is a Firm Fixed Price contract type. It is not a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...

This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, with a ceiling value of $1,656.80 and a period of performance through May 21, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...